Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease

摘要

Background. Dual blockade of the renin–angiotensin system (RAS) has been claimed to have a specific renal protective effect in chronic kidney disease (CKD). The present short-term study reports on the feasibility of dual blockade in a consecutive group of patients with CKD stage 3–5.